Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Magnesium Oxide in Chronic Heart Failure
NCT03840226Phase 3Recruiting
- Sponsor
- Sheba Medical Center
- Start
- Aug 2019
- Primary completion
- Jan 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in heart failure (HF) comparing Magnesium with Placebo (2 arms). Primary endpoints: 6-Minute Walk Test Distance at 1 year and Minnesota Living with Heart Failure Questionnaire at 1 year. Started Aug 2019; status: recruiting.
02
Drugs
magnesium
03
Conditions
heart failure (HF)
Beyond the preview
Go deeper on NCT03840226.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03840226.